Brief: XORTX Therapeutics Announces Positive Phase 2 Results In Type 2 Diabetic Nephropathy
20/09/2019 02:13
Sept 19 (Reuters) - XORTX Therapeutics Inc XRX.CD :
* XORTX ANNOUNCES POSITIVE PHASE 2 RESULTS IN TYPE 2
DIABETIC
NEPHROPATHY (T2DN)
* XORTX THERAPEUTICS INC - STUDY ACHIEVED PRIMARY ENDPOINT
FOR
EFFICACY OF THIS STUDY AND TMX-049 WAS WELL TOLERATED
Source text for Eikon: ID:nGNX2QpBg0
Further company coverage: XRX.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering
Brief: Xortx Announces Closing Of Acquisition Of Vectus Kidney Anti-Fibrotic Asset
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM